Journal of Thoracic Oncology. 2007 Aug;2(8):780-1. [Link]

Doval DC, Pande SB, Sharma JB, Rao SA, Prakash N, Vaid AK.

Department of Medical Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India. dcdoval@yahoo.com

Abstract

Pericardial mesothelioma remains a disease with a bleak prognosis. We report the case of a patient with metastases to liver and good response to pemetrexed and carboplatin-based combination chemotherapy and consequent prolonged progression-free survival.

Posted in Carboplatin, Case Study, Chemotherapy, Determining Efficacy, Full Archive, Pemetrexed (Alimta), Pericardial, Survival, Treatment, Type of Assessment:, Type of Mesothelioma: